Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Recruiting	Phase 2	2025-05-15		NCT06453317

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań	1
Medical Research Agency, Poland	33
Medical University of Lodz	17
Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz	1
Poznan University of Medical Sciences	53

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Oddział Kliniczny Gastroenterologii Ogólnej i Onkologicznej USK nr 1 im. N. Barlickiego w Łodzi	Lodz	Poland	1